Use of genome-wide association studies for drug repositioning

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Nature Biotechnology

• Publication date

  2012-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/nbt.2151PMID 22491277
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

  2011cited by this paper
• Database identifies FDA-approved drugs with potential to be repurposed for treatment of orphan diseases

  2011cited by this paper
• Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

  2010cited by this paper
• Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly.

  2010cited by this paper
• Multiple common variants for celiac disease influencing immune gene expression

  2010cited by this paper
• E2-2 protein and Fuchs's corneal dystrophy.

  2010cited by this paper
• Genome-wide association analysis identifies three psoriasis susceptibility loci

  2010cited by this paper
• Genome-wide meta-analyses identify multiple loci associated with smoking behavior

  2010cited by this paper
• Replication of the LINGO1 gene association with essential tremor in a North American population

  2010cited by this paper
• Common variants at five new loci associated with early-onset inflammatory bowel disease

  2009cited by this paper
• Variant in the sequence of the LINGO1 gene confers risk of essential tremor

  2009cited by this paper
• New sequence variants associated with bone mineral density

  2009cited by this paper
• Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

  2008cited by this paper
• Genomewide Scan Reveals Association of Psoriasis with IL-23 and NF-κB Pathways

  2008cited by this paper
• Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans

  2008cited by this paper
• Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes

  2007cited by this paper
• The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss

  2005cited by this paper
• Essential tremor.

  2005cited by this paper
• Treatment of psoriasis with topical NG‐monomethyl‐ l‐arginine, an inhibitor of nitric oxide synthesis

  2000cited by this paper
• Detection of nitric oxide and nitric oxide synthases in psoriasis

  1998cited by this paper
• E2-2 Protein and Fuchs's Corneal Dystrophy

  year unknowncited by this paper

• EVALUATION OF LG’S ANTICANCER ACTİVİTY ON HUMAN GASTRIC CANCER CELL LINE HGC-27 VIA MOLECULAR DOCKING AND GENE EXPRESSION ANALYSIS

  2026cites this paper
• A genetics-guided integrative framework for drug repurposing: identifying antihypertensive drugs for type 2 diabetes

  2026influential citation
• Navigating the Computational Landscape for Drug Repurposing.

  2026cites this paper
• DrugReX: an explainable drug repurposing system powered by large language models and literature-based knowledge graph

  2025cites this paper
• Genome‐Wide Association Study of Cognitive Function in Population‐Based Cohorts in Japan: The Tohoku Medical Megabank Brain Magnetic Resonance Imaging Study

  2025cites this paper
• Drug repurposing: a promising drug discovery strategy for the treatment of emerging epidemic infectious disease

  2025cites this paper
• A survey on computational methods used for drug repositioning

  2025cites this paper
• Innovative horizons: harnessing drug repositioning for targeted therapeutics in colorectal cancer

  2025cites this paper
• Artificial intelligence in traditional Chinese medicine: from systems biological mechanism discovery, real-world clinical evidence inference to personalized clinical decision support.

  2025cites this paper
• A Genetics-guided Integrative Framework for Drug Repurposing: Identifying Anti-hypertensive Drug Telmisartan for Type 2 Diabetes

  2025influential citation
• Computational drug repurposing for viral infectious diseases: a case study on monkeypox.

  2024cites this paper
• The future of metronomic chemotherapy: experimental and computational approaches of drug repurposing

  2024cites this paper
• Linking Genome-Wide Association Studies to Pharmacological Treatments for Psychiatric Disorders.

  2024cites this paper
• Exploring the potential of drug repurposing for treating depression.

  2024cites this paper
• The importance of functional genomics studies in precision rheumatology.

  2024cites this paper
• Genetic and Epigenetic Landscape for Drug Development in Polycystic Ovary Syndrome.

  2024cites this paper
• Drug repurposing for metabolic disorders: Scientific, technological and economic issues.

  2024cites this paper
• Exome-wide sequencing study identified genetic variants associated with sarcopenic obesity.

  2024cites this paper
• Navigating the Intersection of Technology and Depression Precision Medicine.

  2024cites this paper
• Novel strategies for drug repurposing.

  2024cites this paper
• Multi-Network Based Approach for Drug Repurposing

  2024cites this paper
• Repurposing of biologics and biopharmaceuticals.

  2024cites this paper
• Utility of polygenic risk scores to aid in the diagnosis of rheumatic diseases.

  2024cites this paper
• Current trends and future prospects of drug repositioning in gastrointestinal oncology

  2024cites this paper
• Evolution of the Drug Repurposing Paradigm

  2024cites this paper
• A Deep Subgrouping Framework for Precision Drug Repurposing via Emulating Clinical Trials on Real-world Patient Data

  2024cites this paper
• Atlas of the plasma proteome in health and disease in 53,026 adults.

  2024cites this paper
• The effect of fampridine on working memory: a randomized controlled trial based on a genome-guided repurposing approach

  2024cites this paper
• Genomic strategies for drug repurposing

  2024cites this paper
• Shared molecular, cellular, and environmental hallmarks in cardiovascular disease and cancer: Any place for drug repurposing?

  2024cites this paper
• HeteroRepur: Efficient Modeling of Heterogeneous Disease Graph for Depression Drug Repurposing using Heterogeneous Graph Neural Networks

  2024cites this paper
• Drug repurposing—a promising approach for patients with angina but non-obstructive coronary artery disease (ANOCA)

  2023cites this paper
• A review on Artificial Intelligence Approaches and Rational approaches in Drug Discovery.

  2023cites this paper
• Drug Repurposing: Insights into Current Advances and Future Applications.

  2023cites this paper
• Genetic and Gene Expression Resources for Osteoporosis and Bone Biology Research

  2023cites this paper
• New “drugs and targets” in the GWAS era of bipolar disorder

  2023cites this paper
• New drug-like small molecule antagonizes phosphatidylinositol (3,4,5)-trisphosphate (PIP3) in patients with conotruncal heart defects

  2023cites this paper
• Harnessing the Power of Electronic Health Records and Genomics for Drug Discovery.

  2023cites this paper
• Examining the shared etiology of psychopathology with genome-wide association studies.

  2023cites this paper
• Drug Repurposing in Non-Small Cell Lung Carcinoma: Old Solutions for New Problems

  2023cites this paper
• Myocardial Recovery in Recent Onset Dilated Cardiomyopathy: Role of CDCP1 and Cardiac Fibrosis

  2023cites this paper
• Germline mechanisms of immunotherapy toxicities in the era of genome‐wide association studies

  2023cites this paper
• Overcoming Drug Resistance in Advanced Prostate Cancer by Drug Repurposing

  2022cites this paper
• The druggable schizophrenia genome: from repurposing opportunities to unexplored drug targets

  2022cites this paper
• Integrating gene expression and clinical data to identify drug repurposing candidates for hyperlipidemia and hypertension

  2022cites this paper
• Transcriptome-Guided Identification of Drugs for Repurposing to Treat Age-Related Hearing Loss

  2022cites this paper
• Genetics of common cerebral small vessel disease

  2022cites this paper
• Bibliometric and Visual Analysis on Metabolomics in Coronary Artery Disease Research

  2022cites this paper
• KGML-xDTD: a knowledge graph–based machine learning framework for drug treatment prediction and mechanism description

  2022cites this paper
• The druggable schizophrenia genome: from repurposing opportunities to unexplored drug targets

  2022cites this paper
• A genetically supported drug repurposing pipeline for diabetes treatment using electronic health records

  2022cites this paper
• Deep learning identifies explainable reasoning paths of mechanism of action for drug repurposing from multilayer biological network

  2022cites this paper
• Identification of Potential Treatments for Acute Lymphoblastic Leukemia through Integrated Genomic Network Analysis

  2022cites this paper
• Drug repurposing: a systematic review on root causes, barriers and facilitators

  2022cites this paper
• Pharmacometabolomics-Based Translational Biomarkers: How to Navigate the Data Ocean

  2022cites this paper
• StarGazer: A Hybrid Intelligence Platform for Drug Target Prioritization and Digital Drug Repositioning Using Streamlit

  2022cites this paper
• Target Discovery for Drug Development Using Mendelian Randomization.

  2022cites this paper
• Repurposing drugs to treat cardiovascular disease in the era of precision medicine

  2022cites this paper
• BGAT: A Multi Information Fusion Drug Repurposing Framework Based on Graph Convolutional Network

  2022cites this paper
• Pharmacogenomics for the efficacy and side effects of antihistamines

  2022cites this paper
• Combinational Drug Repurposing from Genetic Networks Applied to Alzheimer’s Disease

  2022cites this paper
• Linking GWAS to pharmacological treatments for psychiatric disorders

  2022cites this paper
• Using common genetic variants to find drugs for common epilepsies

  2021cites this paper
• Can Any Drug Be Repurposed for Cancer Treatment? A Systematic Assessment of the Scientific Literature

  2021cites this paper
• Repurposing Market Drugs to Target Epigenetic Enzymes in Human Diseases

  2021cites this paper
• Considerations and challenges for sex-aware drug repurposing

  2021cites this paper
• Artificial Intelligence in Medicine: Biochemical 3D Modeling and Drug Discovery

  2021cites this paper
• Systems Biology Approaches to Decipher the Underlying Molecular Mechanisms of Glioblastoma Multiforme

  2021cites this paper
• Repositioning drugs for systemic lupus erythematosus

  2021cites this paper
• Why promising drugs are shelved and barriers and facilitators to re-purposing them: A systematic literature review

  2021cites this paper
• Human Protein Complex-Based Drug Signatures for Personalized Cancer Medicine

  2021cites this paper
• Using Human Genetics to Understand Mechanisms in Ischemic Stroke Outcome

  2021cites this paper
• Mendelian randomization for studying the effects of perturbing drug targets [version 1; peer review: awaiting peer review]

  2021cites this paper
• Drug Repurposing: Claiming the Full Benefit from Drug Development

  2021cites this paper
• Modern Tools and Techniques in Computer-Aided Drug Design

  2021cites this paper
• Drug repurposing for COVID-19: Approaches, challenges and promising candidates

  2021cites this paper
• Computer-Aided Drug Design for Cancer Therapy

  2021cites this paper
• The tumor therapy landscape of synthetic lethality

  2021cites this paper
• Predicting therapeutic drugs for hepatocellular carcinoma based on tissue-specific pathways

  2021influential citation
• Advancing drug discovery using the power of the human genome

  2021cites this paper
• Identifying Novel Drug Targets by iDTPnd: A Case Study of Kinase Inhibitors

  2021cites this paper
• Mendelian randomization for studying the effects of perturbing drug targets

  2021cites this paper
• Systematic in silico Evaluation of Leishmania spp. Proteomes for Drug Discovery

  2021cites this paper
• The Interface of Therapeutics and Genomics in Cardiovascular Medicine

  2021cites this paper
• Twelve years of GWAS discoveries for osteoporosis and related traits: advances, challenges and applications

  2021influential citation
• A deep learning framework for drug repurposing via emulating clinical trials on real-world patient data

  2021cites this paper
• The complexity of Alzheimer's disease: an evolving puzzle.

  2021cites this paper
• Genomic Medicine: Lessons Learned From Monogenic and Complex Bone Disorders

  2020cites this paper
• The support of genetic evidence for cardiovascular risk induced by antineoplastic drugs

  2020cites this paper
• GEFA: Early Fusion Approach in Drug-Target Affinity Prediction

  2020cites this paper
• Computational Drug Repositioning: Current Progress and Challenges

  2020cites this paper
• Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak

  2020influential citation
• A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions

  2020cites this paper
• The Musculoskeletal Knowledge Portal: Making Omics Data Useful to the Broader Scientific Community

  2020influential citation
• The Psychiatric Genomics Consortium: History, development, and the future

  2020cites this paper
• When deep learning meets causal inference: a computational framework for drug repurposing from real-world data

  2020cites this paper
• Genome‐wide pathogenesis interpretation using a heat diffusion‐based systems genetics method and implications for gene function annotation

  2020cites this paper
• Repurposing of medications for pulmonary arterial hypertension

  2020cites this paper
• Harnessing Drug Repurposing for Exploration of New Diseases: An Insight to Strategies and Case Studies.

  2020cites this paper
• Current Status of COVID-19 Therapies and Drug Repositioning Applications

  2020cites this paper